repaglinide
Showing 1 - 25 of 47
Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)
Completed
- Malaria
- Midazolam
- +7 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Nov 2, 2022
Healthy Participants Trial in Salt Lake City (DC-806, Midazolam, Repaglinide)
Not yet recruiting
- Healthy Participants
- DC-806
- +4 more
-
Salt Lake City, UtahICON Phase 1 Clinic
Oct 16, 2023
Sickle Cell Disease Trial in San Antonio (Voxelotor, Bupropion, Repaglinide)
Recruiting
- Sickle Cell Disease
- Voxelotor
- +8 more
-
San Antonio, TexasICON Early Phase Services, LLC
Jul 31, 2023
GIST - Gastrointestinal Stromal Tumor Trial in Jacksonville, Miami, Portland (Ripretinib, Repaglinide)
Recruiting
- GIST - Gastrointestinal Stromal Tumor
- Ripretinib
- Repaglinide
-
Jacksonville, Florida
- +2 more
Mar 7, 2022
Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)
Completed
- Type 2 Diabetes Mellitus
- INSULIN GLARGINE (HOE901)
- +5 more
-
China, ChinaCHINA
Apr 21, 2022
Mitochondrial Disease Trial in Leeds (KL1333, Flurbiprofen, Dextromethorphan)
Completed
- Mitochondrial Disease
- KL1333
- +7 more
-
Leeds, United KingdomVolunteer recruitment center Covance Leeds Covance Leeds
Oct 19, 2021
Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York
Completed
- Diffuse Large B Cell Lymphoma
- +4 more
- Tazemetostat
- +3 more
-
Tucson, Arizona
- +2 more
Mar 23, 2021
Diabetes, Type 2 Trial in Leicester, Birmingham (Canagliflozin, Repaglinide, Pioglitazone)
Completed
- Diabetes Mellitus, Type 2
- Canagliflozin
- +4 more
-
Leicester, Leicestershire, United Kingdom
- +1 more
Jan 29, 2020
Diabetes Trial in Palermo (Dulaglutide, Aspart insulin, Glargine)
Completed
- Diabetes Mellitus
- Dulaglutide
- +4 more
-
Palermo, ItalyInternal Medicine Ward, University of Palermo
Jan 29, 2019
Diabetes, Diabetes, Type 2 Trial in Beijing, Shanghai (repaglinide, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- metformin
-
Beijing, Beijing, China
- +2 more
Feb 17, 2017
Diabetes, Diabetes, Type 2 Trial in Houston (repaglinide, glyburide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- glyburide
-
Houston, TexasNovo Nordisk Investigational Site
Feb 17, 2017
Diabetes, Diabetes, Type 2 Trial in Miami, Tacoma (repaglinide, metformin, repaglinide and metformin combination tablet)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- +2 more
-
Miami, Florida
- +1 more
Feb 9, 2017
Diabetes, Diabetes, Type 2 Trial in Austin (repaglinide, metformin, repaglinide and metformin combination tablet)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- +2 more
-
Austin, TexasNovo Nordisk Investigational Site
Feb 9, 2017
Diabetes, Diabetes, Type 2 Trial in Padova (repaglinide, glyburide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- +2 more
-
Padova, ItalyNovo Nordisk Investigational Site
Feb 17, 2017
Diabetes, Diabetes, Type 2 Trial in Shanghai, Chengdu, Beijing (repaglinide, Glurenorm®, Glucobay®)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- +2 more
-
Shanghai, Shanghai, China
- +3 more
Feb 17, 2017
Diabetes, Diabetes, Type 2 Trial in Athens (repaglinide, biphasic human insulin 30, insulin NPH)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- +2 more
-
Athens, GreeceNovo Nordisk Investigational Site
Feb 17, 2017
Diabetes, Diabetes, Type 2 Trial in China (repaglinide, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- metformin
-
Fuzhou, Fujian, China
- +16 more
Dec 19, 2016
Diabetes, Diabetes, Type 2 Trial in Beijing, Shanghai (repaglinide, isophane human insulin, insulin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- +2 more
-
Beijing, Beijing, China
- +2 more
Feb 17, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (repaglinide, insulin NPH)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide
- insulin NPH
-
Shatin, New Territories, Hong Kong
- +11 more
Feb 17, 2017
Cystic Fibrosis Related Diabetes, Pancreatic Insufficiency Trial in Saint Louis (, repaglinide)
Completed
- Cystic Fibrosis Related Diabetes
- Pancreatic Insufficiency
- placebo
- repaglinide
-
Saint Louis, MissouriWashington University School of Medicine
May 3, 2017